Delhi Health Minister Satyendra Jain on Friday said that the national Capital currently has stocks only for two or three days to vaccinate beneficiaries in the 18-44 years age group.
“The stocks of Covaxin have almost finished and we have only two-three days’ worth of stocks of Covishield vaccines for those in the 18- 44 age group. We can’t mix already assigned centres for Covaxin and Covishield vaccines,” he said.
Jain also urged the Centre to cap the prices of all vaccines in India at `150 per dose.
He asserted that since the supply of Tocilizumab is controlled by the Centre, they have mandated only 1,000 units per month, whereas the demand is much more
Now that three vaccines have been approved for the inoculation in India, Covishield, Covaxin, and Sputnik V, Jain stressed on the need for ‘One Nation, One Policy.’
The Health Minister said, “For Remdesivir and Tocilizumab, all the management and control is in the hands of the Central Government, which is supplied to the hospitals through a website managed by the Centre.”
The Statewise distribution is also being controlled by the Centre.
“The Centre has mandated just 1,000 units of Tocilizumab injection in one month, which means hardly 30 units per day, while the demand is much more than this. Thus, we have passed the order and formed the expert committee to streamline the supply effectively and mobilise it”, he added.
